Surgery Medical News about Early Cytokine Production

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials

3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

4. 2008 Exclusive Survey—Earnings: Good news for primary care income

5. Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Early Cytokine Production Risk Stratifies Trauma Patients for Multiple Organ Failure
Journal of the American College of Surgeons, 07/10/09

Jastrow KM et al. - Shock is a prime inciting event for postinjury multiple organ failure (MOF), believed to induce a state of injurious systemic inflammation. The data provide insight into cytokine expression during traumatic shock that can enable earlier identification of patients at risk for development of MOF.

<< Previous
Massive Transfusion Protocols: The Role of Aggressive...

Next >>
Intravesical bacille Calmette-Guerin therapy for...

Randomized clinical trial of the effect of glucocorticoids on peritoneal inflammation and postoperative recovery after colectomy
British Journal of Surgery, 10/22/09 Relevance Score: 80%

IL-24 protects against Salmonella typhimurium infection by stimulating early neutrophil Th1 cytokine production, which in turn activates CD8+ T cells
European Journal of Immunology, 11/18/09 Relevance Score: 79%

Dipeptidyl peptidase inhibitors, an emerging drug class for inflammatory disease?
Trends in Pharmacological Sciences, 11/06/09 Relevance Score: 79%

Interleukin-10 secretion from CD14+ peripheral blood mononuclear cells is downregulated in patients with acne vulgaris
British Journal of Dermatology, 10/13/09 Relevance Score: 78%

Proinflammatory cytokines synergistically enhance the production of chemokine ligand 20 (CCL20) from rheumatoid fibroblast-like synovial cells in vitro and serum CCL20 is reduced in vivo by biologic disease-modifying antirheumatic drugs
Journal of Rheumatology, 10/05/09 Relevance Score: 69%